Jeanne M Ferrante1, Susan Rovi, Kasturi Das, Steve Kim. 1. Department of Family Medicine, University of Medicine and Dentistry-New Jersey Medical School, Newark, NJ 07101-1709, USA. ferranjm@umdnj.edu
Abstract
BACKGROUND: The specialty of a patient's usual provider of care is associated with use of mammography and stage of breast cancer diagnosis. It is unknown if specialty of usual provider of care affects time from discovery of a breast screening abnormality to diagnostic resolution. METHODS: Retrospective chart review study of 546 women who had breast biopsies at an urban public university hospital from 2001 to 2005. Time from abnormal mammogram or clinical breast examination to pathology report was compared by specialty of usual provider of care, sociodemographic, and clinical factors. Multivariate logistic regression was conducted to assess predictors of having diagnostic interval greater than 60 days. RESULTS: The median diagnostic interval was 36 days (interquartile range 21 to 63). After controlling for age, race, insurance, specialty of usual provider of care, employment status, and palpable lump, decreased odds of having diagnostic delay (over 60 days) included having a family physician (odds ratio (OR) 0.242; 95% confidence interval (CI), 0.09 to 0.69), private health insurance (OR 0.360; 95% CI, 0.15 to 0.89), and cancer diagnosis (OR 0.324; 95% CI, 0.17 to 0.61). CONCLUSIONS: To improve timely follow-up of minority urban women with breast abnormalities, promoting development of a relationship with a family physician may be an important public health intervention.
BACKGROUND: The specialty of a patient's usual provider of care is associated with use of mammography and stage of breast cancer diagnosis. It is unknown if specialty of usual provider of care affects time from discovery of a breast screening abnormality to diagnostic resolution. METHODS: Retrospective chart review study of 546 women who had breast biopsies at an urban public university hospital from 2001 to 2005. Time from abnormal mammogram or clinical breast examination to pathology report was compared by specialty of usual provider of care, sociodemographic, and clinical factors. Multivariate logistic regression was conducted to assess predictors of having diagnostic interval greater than 60 days. RESULTS: The median diagnostic interval was 36 days (interquartile range 21 to 63). After controlling for age, race, insurance, specialty of usual provider of care, employment status, and palpable lump, decreased odds of having diagnostic delay (over 60 days) included having a family physician (odds ratio (OR) 0.242; 95% confidence interval (CI), 0.09 to 0.69), private health insurance (OR 0.360; 95% CI, 0.15 to 0.89), and cancer diagnosis (OR 0.324; 95% CI, 0.17 to 0.61). CONCLUSIONS: To improve timely follow-up of minority urban women with breast abnormalities, promoting development of a relationship with a family physician may be an important public health intervention.
Authors: Christopher J Louis; Jonathan R Clark; Marianne M Hillemeier; Fabian Camacho; Nengliang Yao; Roger T Anderson Journal: J Rural Health Date: 2017-01-19 Impact factor: 4.333
Authors: Robert D Rosenberg; Sebastien J P A Haneuse; Berta M Geller; Diana S M Buist; Diana L Miglioretti; R James Brenner; Rebecca Smith-Bindman; Stephen H Taplin Journal: Radiology Date: 2011-09-07 Impact factor: 11.105
Authors: Richard G Roetzheim; Ji-Hyun Lee; Ercilia R Calcano; Cathy D Meade; William J Fulp; Kristen J Wells Journal: J Health Care Poor Underserved Date: 2012-08
Authors: Lisa C Richardson; Janet Royalty; William Howe; William Helsel; William Kammerer; Vicki B Benard Journal: Am J Public Health Date: 2009-12-17 Impact factor: 9.308
Authors: Kate J Fisher; Ji-Hyun Lee; Jeanne M Ferrante; Ellen P McCarthy; Eduardo C Gonzalez; Ren Chen; Kymia Love-Jackson; Richard G Roetzheim Journal: Cancer Date: 2013-05-15 Impact factor: 6.860
Authors: Richard G Roetzheim; Jeanne M Ferrante; Ji-Hyun Lee; Ren Chen; Kymia M Love-Jackson; Eduardo C Gonzalez; Kate J Fisher; Ellen P McCarthy Journal: Ann Fam Med Date: 2012 Sep-Oct Impact factor: 5.166